Nedisertib or peposertib (also referred to as M3814) represent other DNA-PK inhibitors which have been shown to sensitize tumor cells towards RT (reviewed in [13]) and to selectively accumulate in melanoma brain metastases [40]. The gene discussed is PRKDC; the disease is neoplasm.